William Douglas Figg, Senior is an American scientist at the National Institutes of Health, Bethesda, Maryland.
Education
Figg received a Bachelor of Science (honorary) from Georgetown College (Kentucky) (attended 1981 to 1983), a Bachelor of Science in Pharmacy from Samford University (1987) and a doctoral degree (Doctor of Pharmacy) from Auburn University (1989). He completed an internship at the University of Alabama at Birmingham Hospital and a fellowship in Drug Development at the University of North Carolina at Chapel Hill (1990–1992). He also received an Master of Business Administration degree from a combined program at Columbia University, School of Business and London Business School.
Career
Figg joined the National Cancer Institute, National Institutes of Health in 1992. The following year he became head of the Molecular Pharmacology Section and the Clinical Pharmacology Program. His research is focused on using pharmacological principles to optimize the treatment of cancer, on identifying genes involved in the development of prostate cancer and developing new treatments including angiogenesis inhibitors for men with castration-resistant prostate cancer.
According to Scopus, he is the most well-published scientist in the combined fields of angiogenesis and prostate cancer.
Figg has over 500 peer-reviewed scientific papers and published four books – including the seminal textbook on Angiogenesis with legendary cancer researcher Judah Folkman. Figg is a retired Captain in the United States Public Health Service Commissioned Corps.
Figg is an adjunct faculty member at the University of Michigan (School of Pharmacy), Columbia University (College of Physicians and Surgeons), Samford University (School of Pharmacy), Virginia Commonwealth University (School of Pharmacy) and the University of Maryland (School of Pharmacy). Figg grew up in Beaver Dam, Kentucky and graduated from Ohio County High School, Hartford, Kentucky.